Revisiting CB1 cannabinoid receptor detection and the exploration of its interacting partners

[1]  K. Daniels,et al.  Assessment of quality and consistency of monoclonal antibodies for CB1 and CB2 in head and neck squamous cell carcinoma , 2019, Head & neck.

[2]  A. Köfalvi,et al.  Chronic insulinopenia/hyperglycemia decreases cannabinoid CB1 receptor density and impairs glucose uptake in the mouse forebrain , 2019, Brain Research Bulletin.

[3]  H. Duan,et al.  Expression of Cannabinoid Receptors in Myometrium and its Correlation With Dysmenorrhea in Adenomyosis , 2019, Reproductive Sciences.

[4]  R. Ramer,et al.  Anti‐tumour actions of cannabinoids , 2018, British journal of pharmacology.

[5]  J. Fernández-Ruiz.  The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid‐based therapies to improve on the poor current therapeutic outcomes , 2018, British journal of pharmacology.

[6]  M. García-Arencibia,et al.  Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells , 2018, British journal of pharmacology.

[7]  A. Lichtman,et al.  Methylphenidate modifies the motion of the circadian clock Lamotrigine in mood disorders and cocaine dependence Cortical glutamate in postpartum depression The Endogenous Cannabinoid System : A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain , 2017 .

[8]  Victoria Chapman,et al.  The cannabinoid system and pain , 2017, Neuropharmacology.

[9]  J. Egan,et al.  Targeted proteomics of cannabinoid receptor CB1 and the CB1b isoform , 2017, Journal of pharmaceutical and biomedical analysis.

[10]  K. Mackie,et al.  Discovery and characterization of two novel CB1 receptor splice variants with modified N‐termini in mouse , 2017, Journal of neurochemistry.

[11]  S. Tenzer,et al.  Cell Type-Specific Tandem Affinity Purification of the Mouse Hippocampal CB1 Receptor-Associated Proteome. , 2016, Journal of proteome research.

[12]  G. Gruden,et al.  Role of the endocannabinoid system in diabetes and diabetic complications , 2016, British journal of pharmacology.

[13]  G. Velasco,et al.  Anticancer mechanisms of cannabinoids. , 2016, Current oncology.

[14]  B. Lutz,et al.  The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons , 2015, PLoS biology.

[15]  P. Robledo,et al.  Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors , 2015, PLoS biology.

[16]  P. Piazza,et al.  Cannabinoid control of brain bioenergetics: Exploring the subcellular localization of the CB1 receptor , 2014, Molecular metabolism.

[17]  J. Kukkonen,et al.  Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors. , 2014, Biochemical and biophysical research communications.

[18]  F. Lee,et al.  Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex , 2014, Journal of Molecular Neuroscience.

[19]  R. Laprairie,et al.  Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes. , 2013, European journal of pharmacology.

[20]  P. Rakic,et al.  Antibodies to cannabinoid type 1 receptor co‐react with stomatin‐like protein 2 in mouse brain mitochondria , 2013, The European journal of neuroscience.

[21]  S. Angers,et al.  Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. , 2013, Molecular endocrinology.

[22]  D. Braun,et al.  Structure and function analyses of the purified GPCR human vomeronasal type 1 receptor 1 , 2011, Scientific reports.

[23]  D. Braun,et al.  A Robust and Rapid Method of Producing Soluble, Stable, and Functional G-Protein Coupled Receptors , 2011, PloS one.

[24]  R. Challiss.  Receptor Signal Transduction Protocols , 1997, Methods in Molecular Biology.

[25]  M. von Zastrow,et al.  Analysis of GPCR localization and trafficking. , 2011, Methods in molecular biology.

[26]  N. Birdsall.  Class A GPCR heterodimers: evidence from binding studies. , 2010, Trends in pharmacological sciences.

[27]  F. Bermúdez-Silva,et al.  The endocannabinoid system, eating behavior and energy homeostasis: The end or a new beginning? , 2010, Pharmacology Biochemistry and Behavior.

[28]  Masahiko Watanabe,et al.  Endocannabinoid-mediated control of synaptic transmission. , 2009, Physiological reviews.

[29]  E. S. Graham,et al.  Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! , 2008, Journal of Neuroscience Methods.

[30]  J. Sallés,et al.  Characterization of CB1 cannabinoid receptor immunoreactivity in postmortem human brain homogenates , 2006, Neuroscience.

[31]  Lakshmi A Devi,et al.  μ opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis , 2006, British journal of pharmacology.

[32]  E. Persson,et al.  Expression of functional CB1 cannabinoid receptors in retinoic acid‐differentiated P19 embryonal carcinoma cells , 2006, Journal of neuroscience research.

[33]  V. Marzo,et al.  Endocannabinoid control of food intake and energy balance , 2005, Nature Neuroscience.

[34]  D. Piomelli.  The molecular logic of endocannabinoid signalling , 2003, Nature Reviews Neuroscience.

[35]  G. von Heijne,et al.  Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. , 2003, Molecular pharmacology.

[36]  D. Bilkey,et al.  Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes , 2003, Brain Research.

[37]  I. Díaz-Laviada,et al.  Expression of functionally active cannabinoid receptor CB1 in the human prostate gland , 2003, The Prostate.

[38]  K. Mackie,et al.  Dimerization of G protein-coupled receptors: CB1 cannabinoid receptors as an example. , 2002, Chemistry and physics of lipids.

[39]  G. Gessa,et al.  Evidence for functional CB1 cannabinoid receptor expressed in the rat thyroid. , 2002, European journal of endocrinology.

[40]  C. Deber,et al.  Interhelical hydrogen bonds in the CFTR membrane domain , 2001, Nature Structural Biology.

[41]  A. Howlett,et al.  The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. , 2000, Molecular pharmacology.

[42]  M. Parker,et al.  Expression of cannabinoid receptors and their gene transcripts in human blood cells , 1999, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[43]  M. Herkenham,et al.  Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Henry,et al.  SDS-resistant aggregation of membrane proteins: application to the purification of the vesicular monoamine transporter. , 1996, The Biochemical journal.

[45]  A. Howlett,et al.  Rat brain cannabinoid receptors are N-linked glycosylated proteins. , 1995, Life sciences.

[46]  M. Kaghad,et al.  An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing (*) , 1995, The Journal of Biological Chemistry.

[47]  G. Cabral,et al.  Expression of a cannabinoid receptor in baculovirus-infected insect cells. , 1994, Biochemical pharmacology.

[48]  K. Mackie,et al.  Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Herkenham,et al.  Cannabinoid receptor localization in brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.